Clinical Trial Update: A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating CagriSema versus placebo in adults with type 2 diabetes and painful diabetic peripheral neuropathy; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2, Diabetic Peripheral Neuropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING